Home BioForce Nanosciences

BioForce Nanosciences

In operation
IPO
Nanotechnology R&D Developer, Nanotechnology Instrument Developer

Basic Information

BioForce Nanosciences, Inc. develops and commercializes nanotechnology instruments, consumables, and life science applications. The company has been providing consumable support products for atomic force microscopy (AFM) for over a decade. In 2005, BioForce launched its flagship instrument platform, the Nano eNabler™ system. The Nano eNabler™ system is a molecular printer that rapidly and precisely delivers liquids in droplets 10 billion times smaller than a drop of blood onto surfaces such as silicon chips. This unique capability provides practical solutions for researchers in both industry and academia who encounter challenges in developing ultra-miniaturized devices and methods, creating further opportunities for the commercialization of nanotechnology. It offers consumable support products for atomic force microscopy. The flagship instrument platform of BioForce Nanosciences, the Nano eNabler™, is a molecular printer capable of delivering liquid droplets onto surfaces like silicon chips, offering researchers in industry and academia a practical solution to challenges faced in developing ultra-miniaturized devices and methods. The design sensitivity and specificity of BioForce Nanotechnologies are sufficient to detect a wide range of pathogens, including environmental pathogens, those related to biodefense systems, animal and plant viruses, and human disease research institutions. BioForce Nanotechnologies was founded in 2003 and is headquartered in Ames, Iowa, USA. BioForce Nanotechnologies specializes in cellular differentiation research for BioForce.
BioForce Nanosciences Holdings, Inc.
Iowa,United States of America
15~50 people
January 01, 2003
bioforcecorp@bioforcenano.com